Accuray

CyberKnife Prostate Treatment

Mission: Develop personalized, leading-edge treatment solutions that help cancer patients live longer, better lives. More >

PACE Study: A randomized study comparing surgery, CyberKnife and conventional radiation therapy for early stage prostate cancer. More >

AERO: Accuray Exchange in Radiation Oncology provides a global forum for members to exchange their CyberKnife and TomoTherapy experiences. More >

Events

Radiation Oncologists Congress

Kharkiv, Ukraine (May 21, 2012 - May 22, 2012)
CyberKnife Symposium Finland

Kuopio, Finland (May 23, 2012)
SANTRO

Shangdong, China (May 25, 2012 - May 26, 2012)
Guangzhou Military District Hospital TomoTherapy Center 1st Anniversary Ceremony and Symposium

Guangzhou, China (May 31, 2012)

More >

Accuray Incorporated

Accuray is the premier radiation oncology company. The company develops, manufactures and sells personalized, leading-edge treatment solutions that revolve around the patient. Accuray’s innovative technologies – the CyberKnife and TomoTherapy Systems – set the standard of care with the aim of helping patients live longer, better lives.

CyberKnife® Robotic Radiosurgery System

The CyberKnife System is the world’s only non-invasive robotic radiosurgery system treating tumors anywhere in the body. Continual image guidance technology and robotic mobility tracks, detects and corrects for tumor and patient movement during treatment. High-dose radiation and pinpoint precision minimizes damage to healthy tissue eliminating the need for stabilization frames.

TomoTherapy® System

The TomoTherapy® System establishes a gold standard for radiation therapy, combining revolutionary design, industry-leading treatment precision and daily image guidance for true treatment accuracy. The highly integrated TomoTherapy System assures clinicians and patients that treatments are delivered precisely and safely.